{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:29:24Z","timestamp":1791296964083,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.biopsych.2012.09.007","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T00:17:05Z","timestamp":1349914625000},"page":"993-999","source":"Crossref","is-referenced-by-count":209,"title":["Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects"],"prefix":"10.1016","volume":"73","author":[{"given":"Brian J.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bintou","family":"Gassama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.09.007_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.psc.2007.04.007","article-title":"Epidemiology of schizophrenia: Review of findings and myths","volume":"30","author":"Messias","year":"2007","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.biopsych.2012.09.007_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1176\/appi.ajp.2009.09060908","article-title":"Using bioinformatic tools","volume":"166","author":"Hsu","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.schres.2010.07.001","article-title":"Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data","volume":"122","author":"Jia","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib4","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.09.007_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nature08192","article-title":"Common variants on chromosome 6p22.1 are associated with schizophrenia","volume":"460","author":"Shi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.09.007_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"Common variants conferring risk of schizophrenia","volume":"460","author":"Stefannson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.09.007_bib7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia","volume":"159","author":"Muller","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.schres.2006.11.016","article-title":"Celecoxib as adjunctive therapy in schizophrenia: A doubleblind randomized and placebo-controlled trial","volume":"90","author":"Akhondzadeh","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","article-title":"Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: Results from a randomized, double-blind, placebo controlled trial","volume":"71","author":"Laan","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","article-title":"Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment","volume":"121","author":"M\u00fcller","year":"2010","journal-title":"Schizophr Res"},{"issue":"suppl 2","key":"10.1016\/j.biopsych.2012.09.007_bib11","first-page":"50","article-title":"A double-blind, placebo-controlled trial of celecoxib added to risperidone in first-episode and drug-na\u00efve patients with schizophrenia","volume":"256","author":"Zhang","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2012.09.007_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00406-004-0478-1","article-title":"COX-2 inhibition as a treatment approach in schizophrenia: Immunological considerations and clinical effects of celecoxib add-on therapy","volume":"254","author":"Muller","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2012.09.007_bib13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00415-010-5788-9","article-title":"Disease-relevant autoantibodies in first episode schizophrenia","volume":"258","author":"Zandi","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.biopsych.2012.09.007_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archpsyc.1963.01720180073010","article-title":"Abnormal leukocytes in schizophrenia","volume":"9","author":"Fessel","year":"1963","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00406-010-0098-x","article-title":"Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity","volume":"260","author":"Steiner","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2012.09.007_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-3223(94)91163-0","article-title":"T-cell subsets in acute psychotic schizophrenic patients","volume":"35","author":"Achiron","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-1781(96)03023-5","article-title":"Production of interferon-gamma in families with multiple occurrence of schizophrenia","volume":"66","author":"Arolt","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib19","first-page":"5","article-title":"Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication","volume":"19","author":"Baskak","year":"2008","journal-title":"Turk Psikiyatri Derg"},{"key":"10.1016\/j.biopsych.2012.09.007_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0278-5846(03)00036-8","article-title":"The influence of olanzapine on immune cells in patients with schizophrenia","volume":"27","author":"Bilici","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib21","first-page":"S93a","article-title":"Do systemic inflammation and blood-brain barrier failure play a role in pediatric psychosis?","volume":"76","author":"Carlton","year":"2009","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.biopsych.2012.09.007_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0920-9964(97)00153-9","article-title":"Increased levels of CD8+ and CD4+ 45RA+ lymphocytes in schizophrenic patients","volume":"31","author":"Cazzullo","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psychres.2010.04.049","article-title":"Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia","volume":"187","author":"Chang","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib24","first-page":"113","article-title":"T lymphocytes in schizophrenia","volume":"18","author":"Coffey","year":"1983","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0278-5846(96)00100-5","article-title":"Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy","volume":"20","author":"Cosentino","year":"1996","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib26","doi-asserted-by":"crossref","first-page":"e692","DOI":"10.1371\/journal.pone.0000692","article-title":"Altered T-cell function in schizophrenia: A cellular model to investigate molecular disease mechanisms","volume":"2","author":"Craddock","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2012.09.007_bib27","first-page":"1003","article-title":"An analysis of lymphocyte subpopulations in schizophrenic patients","volume":"17","author":"DeLisi","year":"1982","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.schres.2010.06.003","article-title":"Correlation or coincidence between monocytosis and worsening of psychosis symptoms in veterans with schizophrenia?","volume":"126","author":"Dimitrov","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib29","first-page":"221","article-title":"Endogenous psychoses and T and B lymphocytes","volume":"107","author":"Dvor\u00e1kov\u00e1","year":"1980","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"key":"10.1016\/j.biopsych.2012.09.007_bib30","first-page":"379","article-title":"Effects of psychoactive drugs on in vitro lymphocyte activation","volume":"14","author":"Ferguson","year":"1978","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.biopsych.2012.09.007_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1749-6632.1987.tb35829.x","article-title":"Clinical and laboratory evidence of autoimmunity in acute schizophrenia","volume":"496","author":"Ganguli","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2012.09.007_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-1781(93)90114-V","article-title":"CD5 positive B lymphocytes in schizophrenia: No alteration in numbers or percentage as compared with control subjects","volume":"48","author":"Ganguli","year":"1993","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF01735051","article-title":"T-lymphocyte subpopulations in schizophrenic patients","volume":"239","author":"Henneberg","year":"1990","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"10.1016\/j.biopsych.2012.09.007_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0920-9964(94)00046-B","article-title":"Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia","volume":"15","author":"Hornberg","year":"1995","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib35","series-title":"Virus Immunity and Mental Disorders.","first-page":"307","article-title":"Lymphocyte subsets and schizophrenia","author":"Kaufmann","year":"1987"},{"key":"10.1016\/j.biopsych.2012.09.007_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000408322","article-title":"Blood lymphocytes in schizophrenia\u2013immunological and virological aspects","volume":"12","author":"Kolyaskina","year":"1983","journal-title":"Adv Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib37","series-title":"Virus Immunity and Mental Disorders","first-page":"285","article-title":"Some aspects of immunologic studies in schizophrenia","author":"Kolyaskina","year":"1987"},{"key":"10.1016\/j.biopsych.2012.09.007_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.psychres.2006.06.004","article-title":"T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment","volume":"152","author":"Maino","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0920-9964(90)90008-U","article-title":"Lymphocyte subsets in schizophrenic disorders. Relationship with clinical, neuromorphological and treatment variables","volume":"3","author":"Masserini","year":"1990","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib40","first-page":"177","article-title":"Lymphocytes in schizophrenic patients under therapy: Serological, morphological and cell subset findings","volume":"109","author":"Mazzarello","year":"2004","journal-title":"Ital J Anat Embryol"},{"key":"10.1016\/j.biopsych.2012.09.007_bib41","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archpsyc.1989.01810100032006","article-title":"Increased numbers of CD5+ B lymphocytes in schizophrenic patients","volume":"46","author":"McAllister","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0165-1781(91)90072-W","article-title":"Cellular immunity in schizophrenic patients before and during neuroleptic treatment","volume":"37","author":"M\u00fcller","year":"1991","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0447.1993.tb03331.x","article-title":"T-cells and psychopathology in schizophrenia: Relationship to the outcome of neuroleptic therapy","volume":"87","author":"M\u00fcller","year":"1993","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2012.09.007_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0920-9964(98)00036-X","article-title":"Increased frequency of CD8 positive gamma\/delta T-lymphocytes (CD8+ gamma\/delta+) in unmedicated schizophrenic patients: Relation to impairment of the blood-brain barrier and HLA-DPA\u204e02011","volume":"32","author":"M\u00fcller","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0920-9964(94)00039-B","article-title":"Abnormal distributions of T-lymphocyte subsets in the cerebrospinal fluid of patients with acute schizophrenia","volume":"14","author":"Nikkil\u00e4","year":"1995","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib46","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1176\/ajp.156.11.1725","article-title":"Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes","volume":"156","author":"Nikkil\u00e4","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0920-9964(99)00218-2","article-title":"Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia","volume":"49","author":"Nikkil\u00e4","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0447.1980.tb00584.x","article-title":"Lymphocyte subpopulations in peripheral blood from schizophrenic patients","volume":"61","author":"Nyland","year":"1980","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2012.09.007_bib49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0006-3223(98)00307-2","article-title":"Elevation of CD5+ B lymphocytes in schizophrenia","volume":"46","author":"Printz","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0272-2712(18)30682-6","article-title":"The central nervous system--immune system relationship","volume":"8","author":"Rabin","year":"1988","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.biopsych.2012.09.007_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000026501","article-title":"Immunological dysfunction in schizophrenia: A systematic approach","volume":"37","author":"Rothermundt","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.biopsych.2012.09.007_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/15622970410029905","article-title":"Search for atypical lymphocytes in schizophrenia","volume":"5","author":"Rudolf","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-3223(94)91149-5","article-title":"Changes of immunological functions after acute exacerbation in schizophrenia","volume":"35","author":"Sasaki","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib54","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1006\/jaut.1996.0086","article-title":"No evidence for autoimmunity in schizophrenia","volume":"9","author":"Schattner","year":"1996","journal-title":"J Autoimmun"},{"key":"10.1016\/j.biopsych.2012.09.007_bib55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archpsyc.1985.01790250023003","article-title":"Depression and immunity. Lymphocyte function in ambulatory depressed patients, hospitalized schizophrenic patients, and patients hospitalized for herniorrhaphy","volume":"42","author":"Schleifer","year":"1985","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0920-9964(98)00175-3","article-title":"T-cell subsets in schizophrenia: A comparison between drug-na\u00efve first episode patients and chronic schizophrenic patients","volume":"38","author":"Sperner-Unterweger","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0920-9964(00)00007-4","article-title":"Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients","volume":"47","author":"Theodoropoulou","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib58","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.pnpbp.2008.10.020","article-title":"The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder","volume":"33","author":"Torres","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib59","first-page":"339","article-title":"Aspects of humoral and cellular immunity in schizophrenia","volume":"14","author":"Vartanian","year":"1978","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.biopsych.2012.09.007_bib60","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1176\/ajp.146.5.609","article-title":"Aberrant T cell-mediated immunity in untreated schizophrenic patients: Deficient interleukin-2 production","volume":"146","author":"Villemain","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-1781(99)00125-0","article-title":"Current antipsychotic dose correlates to mononuclear cell counts in the cerebrospinal fluid of psychotic patients","volume":"93","author":"Wahlbeck","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02190280","article-title":"Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients","volume":"246","author":"Wilke","year":"1996","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2012.09.007_bib63","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-91-2-194","article-title":"Immunologic and coagulation disorders in chlorpromazine-treated patients","volume":"91","author":"Zarrabi","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biopsych.2012.09.007_bib64","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0006-3223(95)00598-6","article-title":"Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: Markers of vulnerability of disease?","volume":"40","author":"Zorrilla","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib65","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0006-3223(97)00358-2","article-title":"Leukocyte differentials predict short-term clinical outcome following antipsychotic treatment in schizophrenia","volume":"3","author":"Zorrilla","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/1468-2389.00156","article-title":"Fixed effects vs. random effects meta-analysis models: Implications for cumulative research knowledge","volume":"8","author":"Hunter","year":"2000","journal-title":"International Journal of Selection and Assessment"},{"key":"10.1016\/j.biopsych.2012.09.007_bib67","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00011-008-8078-6","article-title":"Cigarette smoking and innate immunity","volume":"57","author":"Mehta","year":"2000","journal-title":"InflammRes"},{"key":"10.1016\/j.biopsych.2012.09.007_bib68","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/bjsm.2008.050682","article-title":"Association of white blood cell subfraction concentration with fitness and fatness","volume":"44","author":"Johannsen","year":"2008","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.biopsych.2012.09.007_bib69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10253890500100240","article-title":"Stress, glucocorticoids and ageing of the immune system","volume":"8","author":"Bauer","year":"2005","journal-title":"Stress"},{"key":"10.1016\/j.biopsych.2012.09.007_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2006.10.009","article-title":"Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs?","volume":"108","author":"Blum","year":"2007","journal-title":"Immunol Lett"},{"key":"10.1016\/j.biopsych.2012.09.007_bib71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/ern.09.144","article-title":"The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder","volume":"10","author":"Drexhage","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.biopsych.2012.09.007_bib72","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0920-9964(00)00156-0","article-title":"Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia","volume":"50","author":"Kowalski","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib73","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1017\/S1461145710000799","article-title":"Inflammatory gene expression in monocytes of patients with schizophrenia: Overlap and difference with bipolar disorder. A study in naturalistically treated patients","volume":"13","author":"Drexhage","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2012.09.007_bib74","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","article-title":"Neuroinflammation in schizophrenia-related psychosis: A PET study","volume":"50","author":"Doorduin","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2012.09.007_bib75","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: A quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","author":"van Berckel","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpsychires.2006.10.013","article-title":"Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide","volume":"42","author":"Steiner","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-006-0090-8","article-title":"Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization","volume":"112","author":"Steiner","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2012.09.007_bib78","first-page":"35","article-title":"Clinical and immunological characteristics of a subgroup of patients suffering from schizophrenia","volume":"vol. 18","author":"Ganguli","year":"1997"},{"key":"10.1016\/j.biopsych.2012.09.007_bib79","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1176\/ajp.152.9.1291","article-title":"Increases in CSF levels of interleukin-2 in schizophrenia: Effects of recurrence of psychosis and medication status","volume":"152","author":"McAllister","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib80","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-9877(95)90062-4","article-title":"The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence","volume":"45","author":"Smith","year":"1995","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.biopsych.2012.09.007_bib81","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1054\/mehy.2000.1203","article-title":"The Th2-hypothesis of schizophrenia: A strategy to identify a subgroup of schizophrenia caused by immune mechanisms","volume":"56","author":"Schwarz","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.biopsych.2012.09.007_bib82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: Microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2012.09.007_bib83","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1055\/s-2004-832668","article-title":"Mechanisms of relapse prevention in schizophrenia","volume":"37","author":"Muller","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopsych.2012.09.007_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S026418010000059X","article-title":"The natural history of schizophrenia: A five-year follow-up study of outcome and prediction in a representative sample of schizophrenics","volume":"15","author":"Shepherd","year":"1989","journal-title":"Psychol Med Monogr Suppl"},{"key":"10.1016\/j.biopsych.2012.09.007_bib85","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0920-9964(91)90073-Z","article-title":"Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia","volume":"5","author":"Wyatt","year":"1991","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2012.09.007_bib86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00406-012-0290-2","article-title":"Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6","volume":"262","author":"Krause","year":"2012","journal-title":"Eur Arch Psychiatry Clin Neurosci"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312007792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312007792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T05:30:00Z","timestamp":1714455000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312007792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":86,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0006322312007792"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.09.007","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}